Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clinical Genomics Laboratory, |
RCV005052277 | SCV005685402 | uncertain significance | Lymphatic malformation 6 | 2024-11-01 | criteria provided, single submitter | clinical testing | A PIEZO1 c.430A>G (p.Arg144Gly) variant was identified at a near heterozygous allelic fraction of 46.86%, a frequency which may be consistent with it being of germline origin. This variant, to our knowledge, has not been reported in the medical literature. The PIEZO1 c.430A>G (p.Arg144Gly) variant is only observed on 2/1,535,684 alleles in the general population (gnomAD v.4.1.0), indicating it is not a common variant. Computational predictors suggest that the variant does not impact PIEZO1 function. Due to limited information, and based on ACMG/AMP guidelines for variant interpretation (Richard S et al., PMID: 25741868), the clinical significance of this variant is uncertain at this time. |